{{Drugbox
| Verifiedfields = 
| Watchedfields = 
| verifiedrevid = 
| IUPAC_name = (1S,2R,10R,11S,14R,15S)-14-ethynyl-14-hydroxy-15-methyl-17-methylidenetetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadeca-6,12-dien-5-one
| image = Tosagestin.svg
| width = 

<!--Clinical data-->
| tradename = 
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
| pregnancy_US = <!-- A / B            / C / D / X -->
| pregnancy_category = 
| legal_AU = <!-- Unscheduled / S2 / S3 / S4 / S5 / S6 / S7 / S8 / S9 -->
| legal_CA = 
| legal_UK = 
| legal_US = 
| legal_status = 
| routes_of_administration = [[Oral administration|Oral]]

<!--Pharmacokinetic data-->
| bioavailability = 
| protein_bound = 
| metabolism = 
| elimination_half-life = 
| excretion =

<!--Identifiers-->
| CAS_number_Ref = 
| CAS_number = 110072-15-6
| CAS_supplemental = 
| ATC_prefix = 
| ATC_suffix = 
| PubChem = 159355
| DrugBank_Ref = 
| DrugBank = 
| ChemSpiderID_Ref = 
| ChemSpiderID = 140146
| UNII = YS7Z529O22
| ChEMBL = 2107658
| KEGG = D06197

<!--Chemical data-->
| C=21 | H=24 | O=2
| molecular_weight = 308.41406 g/mol
| smiles = CC12CC(=C)C3C(C1C=CC2(C#C)O)CCC4=CC(=O)CCC34
| StdInChI_Ref = 
| StdInChI = 1S/C21H24O2/c1-4-21(23)10-9-18-17-7-5-14-11-15(22)6-8-16(14)19(17)13(2)12-20(18,21)3/h1,9-11,16-19,23H,2,5-8,12H2,3H3/t16-,17-,18-,19+,20-,21-/m0/s1
| StdInChIKey_Ref = 
| StdInChIKey = YJSTYQGZKJHXLN-OLGWUGKESA-N
| synonyms = Exogestin, letogestin<ref name="NegwerScharnow2001">{{cite book|author1=Martin Negwer|author2=Hans-Georg Scharnow|title=Organic-chemical drugs and their synonyms: (an international survey)|url=https://books.google.com/books?id=zmpqAAAAMAAJ|year=2001|publisher=Wiley-VCH|isbn=978-3-527-30247-5|page=2104}}</ref>
}}

'''Tosagestin''' ([[International Nonproprietary Name|INN]], [[United States Adopted Name|USAN]]) (developmental code name '''Org 30659'''), also known as '''11-methylene-δ<sup>15</sup>-norethisterone''' or '''17α-ethynyl-11-methylene-19-nor-δ<sup>15</sup>-testosterone''', is a selective, [[steroid]]al [[progestin]] of the [[19-nortestosterone]] group that was under development by [[Organon]] in the [[United States]] and [[Europe]] as a [[hormonal contraceptive]] (in combination with [[ethinylestradiol]]) and for the treatment of [[menopausal]] symptoms but was never marketed.<ref name="WHOINNStems2013">{{citation | author = World Health Organization | title = The use of stems in the selection of International Nonproprietary Names (INN) for pharmaceutical substances | year = 2013 | page = 95 | url = http://apps.who.int/medicinedocs/collect/medicinedocs/pdf/s4895e/s4895e.pdf}}</ref><ref name="AdisInsight">{{citation | title = Tosagestin | author = AdisInsight | publisher = Springer | accessdate = 12 July 2016 | url = http://webcache.googleusercontent.com/search?q=cache:GunWHn-ThlcJ:adisinsight.springer.com/drugs/800012399+&cd=1&hl=en&ct=clnk&gl=us}}</ref><ref name="pmid9806953">{{cite journal | vauthors = Verhoeven CH, Krebbers SF, Wagenaars GN, Booy CJ, Groothuis GM, Olinga P, Vos RM | title = In vitro and in vivo metabolism of the progestagen Org 30659 in several species | journal = Drug Metab. Dispos. | volume = 26 | issue = 11 | pages = 1102–12 | year = 1998 | pmid = 9806953 | doi = | url = http://dmd.aspetjournals.org/content/26/11/1102.long}}</ref><ref name="de VisserUchida2003">{{cite journal|last1=de Visser|first1=S.J.|last2=Uchida|first2=N.|last3=van Vliet-Daskalopoulou|first3=E.|last4=Fukazawa|first4=I.|last5=van Doorn|first5=M.B.A.|last6=van den Heuvel|first6=M.W.|last7=Machielsen|first7=C.S.M.|last8=Uchida|first8=E.|last9=Cohen|first9=A.F.|title=Pharmacokinetic differences between Caucasian and Japanese subjects after single and multiple doses of a potential combined oral contraceptive (Org 30659 and EE)|journal=Contraception|volume=68|issue=3|year=2003|pages=195–202|issn=0010-7824|doi=10.1016/S0010-7824(03)00140-9|pmid=14561540}}</ref><ref name="ObrucaKorver2001">{{cite journal|last1=Obruca|first1=Andreas|last2=Korver|first2=Tjeerd|last3=Huber|first3=Johannes|last4=Killick|first4=Stephen R|last5=Landgren|first5=Britt-Marie|last6=Struijs|first6=Martin J|title=Ovarian function during and after treatment with the new progestagen Org 30659|journal=Fertility and Sterility|volume=76|issue=1|year=2001|pages=108–115|issn=0015-0282|doi=10.1016/S0015-0282(01)01824-6|pmid=11438328}}</ref>

==See also==
* [[Gestodene]]

==References==
{{Reflist|2}}

==External links==
* [http://webcache.googleusercontent.com/search?q=cache:GunWHn-ThlcJ:adisinsight.springer.com/drugs/800012399+&cd=1&hl=en&ct=clnk&gl=us Tosagestin - AdisInsight]

{{Progesterone receptor modulators}}

[[Category:Estranes]]
[[Category:Hormonal contraception]]
[[Category:Progestogens]]


{{genito-urinary-drug-stub}}
{{steroid-stub}}